Abstract: An essential task in smart grids is the monitoring of power grid operation - especially, if grids are small (microgrids) and energy generation is volatile. Since simulations cannot cover all ...

https://www.thehindubusinessline.com/economy/logistics/pm-modi-inaugurates-phase-2b-of-mumbai-metro-line-3-calls-it-major-boost-to-citys-connectivity/article70138881 ...

Mumbai Metro Line 3 (Aqua Line) is all set to open its final phase on October 8 (Wednesday). The line runs from Science Centre in the north to Cuffe Parade in the south, covering 11 key stations in ...

Investing.com -- Cidara Therapeutics Inc (NASDAQ:CDTX) stock surged 13.7% following the company’s announcement of updates to its planned Phase 3 registrational trial for CD388 after an End-of-Phase 2 ...

PLYMOUTH MEETING, Pa., September 24, 2025--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the ...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ZYN002 in Fragile X syndrome (FXS). Fragile X syndrome ...

Positive results show that the average weight loss was 12.5 kg (11.8% body weight reduction) with cagrilintide compared to 2.5 kg (2.3%) with placebo, after 68 weeks *1,2 Cagrilintide was ...

Natural Gas Generator 120 kW US 20000-60000 / Set 1 Set/Sets (Min.Order) CE approved generator production of electricity from biogas US 26000-27100 / Set 1 Set/Sets (Min.Order) CE approved biogas ...

[Electronoobs] is using some brushless motors to make a DIY wind turbine. His recent video isn’t about the turbine itself, but a crucial electronic part: the three-phase rectifier. The reason it is so ...

What Happened: The New York-based clinical-stage biopharmaceutical company received final meeting minutes from the U.S. Food and Drug Administration confirming alignment on a registrational path for ...

For Novartis, this week is all about ianalumab. A day after posting a pair of phase 3 wins for the tricky indication of Sjögren's syndrome, the Swiss pharma has unveiled a separate late-stage victory ...